Stroke Prevention Flashcards
Non-modifiable Risk Factors
age, male sex, african american or hispanic, and family history
Modifiable Risk Factors
HTN, Afib, HLD, tobacco smoking, TIA, alcohol/drug use
Blood Pressure Goal
<130/80 mm Hg
CHADS2VASC Score
Afib Stroke Risk
C: CHF
H: HTN
A2: age =/>75 years
D: diabetes
S2: prior stroke/TIA
V: vascular disease
A: age 65-74 years
Sc: sex category (female)
At whats CHADSVASC score do we anticoagulate?
2
After Afib, when do primary prevent with Aspirin
patients greater than 75 years old with no other risk factors
After Afib, when do primary prevent with Warfarin
patients with chadvasc score 2 or greater
Secondary Prevention
have ALREADY had a stroke
If stroke is atherothrombotic, lacunar, or cryptogenic use:
antiplatelet therapy
If stroke is high-risk cardioembolic related (afib) use:
Anticoagulant
If afib is valvular anticoagulate with:
warfarin
If afib is non-valvular anticoagulate with:
DOAC
Aspirin drug interactions
P-450 inhibitors and inducers
Plavix adverse effect
thrombotic thrombocytopenic purpura
- will appear within one month and if it does D/C
Clopidogrel and preferred PPI
pantoprazole (least likely to interact)
lansoprazole and rabeprazole
Is Plavix approved for primary prevention of stroke?
NO
When is plavix first line for secondary prevention of stroke?
patients with peripheral arterial disease or are allergic to ASA
Dipryridamole (aggrenox)
third line antiplatelet
A/E: headache bc of vasodilation
When is double antiplatelet therapy indicated?
as secondary prevention for patients with minor stroke (NIHSS 3 or less) or TIA initiated within 24 hours
**for 21 days